Epithelial-Mesenchymal Transition and Breast Cancer Stem Cells in Breast Cancer Progression - Advances in Breast Cancer Research

ABCR > Vol.11 No.2, April 2022

Advances in Breast Cancer Research

Volume 11, Issue 2 (April 2022)

ISSN Print: 2168-1589 ISSN Online: 2168-1597

Google-based Impact Factor: 0.43 Citations

Epithelial-Mesenchymal Transition and Breast Cancer Stem Cells in Breast Cancer Progression ()

HTML XML

Download as PDF (Size: 968KB) PP. 141-151

DOI: 10.4236/abcr.2022.112012 339 Downloads 1,726 Views Citations

Author(s)

Wanyue Han^*, Qingshan Li^*, Qing Zhang, Fan Xu^#

Affiliation(s)

The Affiliated Hospital of Chengde Medical University, Chengde, China.

ABSTRACT

Breast cancer stem cells (BCSCs) are a small subpopulation of cancer cells having the ability of self-renewing and multi-lineage differentiation, which have also been termed as “tumor-initiating cells”. And in recent years, the role of epithelial mesenchymal transition (EMT) in malignant tumors has been valued. This paper will briefly review and discuss the relationship between BCSCs and EMT.

KEYWORDS

Epithelial-Mesenchymal Transition, Breast Cancer Stem Cells, E-Cadherin, Vimentin, Signaling Pathway

Share and Cite:

Han, W. , Li, Q. , Zhang, Q. and Xu, F. (2022) Epithelial-Mesenchymal Transition and Breast Cancer Stem Cells in Breast Cancer Progression. Advances in Breast Cancer Research, 11, 141-151. doi: 10.4236/abcr.2022.112012.

Cited by

[1]	Isorhamnetin induces apoptosis and suppresses metastasis of human endometrial carcinoma Ishikawa cells via endoplasmic reticulum stress promotion and matrix …
	Foods, 2022

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies